Health Care: Drugs

Lexicon Pharmaceuticals Inc (LXRX: NASDAQ)

$16.32 -0.14 | -0.85%
07/29/16 - 09:46 AM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 130.01M 22.85M 2.22M 1.09M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 130.01M 22.85M 2.22M 1.09M
Selling, General, and Administrative Expenses 23.84M 19.41M 17.12M 17.04M
Research & Development 95.19M 89.28M 89.68M 82.57M
Operating Income before D & A (EBITDA) 10.99M -85.84M -104.58M -98.53M
Depreciation & Amortization 1.25M 2.03M 2.86M 4.19M
Interest Income 572.00K 2.25M 157.00K 213.00K
Other Income - Net 0.00 0.00 59.00K -9.78M
Special Income / Charges -9.52M -14.53M 2.21M 0.00
Total Income Before Interest Expenses (EBIT) 793.00K -100.14M -105.02M -112.29M
Interest Expense 6.72M 2.25M 1.97M 2.11M
Pre-Tax Income -5.93M -102.39M -106.99M -114.40M
Income Taxes 0.00 -70.00K 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -4.68M -100.29M -104.13M -110.21M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -4.68M -100.29M -104.13M -110.21M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -4.68M -100.29M -104.13M -110.21M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
4.84M -85.76M -106.34M -110.21M
Preferred Dividends
Net Income Available To Common -4.68M -100.29M -104.13M -110.21M
Basic EPS from Continuing Ops. -0.05 -1.33 -1.40 -1.61
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.05 -1.33 -1.40 -1.61
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.05 -1.33 -1.40 -1.61
Basic Normalized Net Income/Share 0.05 -1.14 -1.43 -1.61
EPS fr Continuing Ops. -0.05 -1.33 -1.40 -1.61
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.05 -1.33 -1.40 -1.61
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.05 -1.33 -1.40 -1.61
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.05 -1.14 -1.43 -1.61
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with LXRX

Latest LXRX Headlines from TheStreet

More Financial News for LXRX

Press Releases for LXRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter